S&P 500   4,554.57 (+0.09%)
DOW   35,701.12 (+0.76%)
QQQ   388.82 (-0.25%)
AAPL   189.18 (-0.10%)
MSFT   378.78 (-0.02%)
META   329.97 (-0.67%)
GOOGL   134.13 (-0.64%)
AMZN   146.06 (-0.18%)
TSLA   242.11 (-0.83%)
NVDA   477.08 (-0.90%)
NIO   7.28 (+1.39%)
BABA   74.35 (-0.43%)
AMD   122.36 (-1.20%)
T   16.45 (+0.92%)
F   10.48 (-1.04%)
MU   76.03 (-0.86%)
CGC   0.56 (-0.20%)
GE   119.79 (+0.78%)
DIS   92.95 (+0.49%)
AMC   6.96 (-2.93%)
PFE   30.04 (-0.13%)
PYPL   57.52 (-0.78%)
XOM   103.80 (+1.43%)
S&P 500   4,554.57 (+0.09%)
DOW   35,701.12 (+0.76%)
QQQ   388.82 (-0.25%)
AAPL   189.18 (-0.10%)
MSFT   378.78 (-0.02%)
META   329.97 (-0.67%)
GOOGL   134.13 (-0.64%)
AMZN   146.06 (-0.18%)
TSLA   242.11 (-0.83%)
NVDA   477.08 (-0.90%)
NIO   7.28 (+1.39%)
BABA   74.35 (-0.43%)
AMD   122.36 (-1.20%)
T   16.45 (+0.92%)
F   10.48 (-1.04%)
MU   76.03 (-0.86%)
CGC   0.56 (-0.20%)
GE   119.79 (+0.78%)
DIS   92.95 (+0.49%)
AMC   6.96 (-2.93%)
PFE   30.04 (-0.13%)
PYPL   57.52 (-0.78%)
XOM   103.80 (+1.43%)
S&P 500   4,554.57 (+0.09%)
DOW   35,701.12 (+0.76%)
QQQ   388.82 (-0.25%)
AAPL   189.18 (-0.10%)
MSFT   378.78 (-0.02%)
META   329.97 (-0.67%)
GOOGL   134.13 (-0.64%)
AMZN   146.06 (-0.18%)
TSLA   242.11 (-0.83%)
NVDA   477.08 (-0.90%)
NIO   7.28 (+1.39%)
BABA   74.35 (-0.43%)
AMD   122.36 (-1.20%)
T   16.45 (+0.92%)
F   10.48 (-1.04%)
MU   76.03 (-0.86%)
CGC   0.56 (-0.20%)
GE   119.79 (+0.78%)
DIS   92.95 (+0.49%)
AMC   6.96 (-2.93%)
PFE   30.04 (-0.13%)
PYPL   57.52 (-0.78%)
XOM   103.80 (+1.43%)
S&P 500   4,554.57 (+0.09%)
DOW   35,701.12 (+0.76%)
QQQ   388.82 (-0.25%)
AAPL   189.18 (-0.10%)
MSFT   378.78 (-0.02%)
META   329.97 (-0.67%)
GOOGL   134.13 (-0.64%)
AMZN   146.06 (-0.18%)
TSLA   242.11 (-0.83%)
NVDA   477.08 (-0.90%)
NIO   7.28 (+1.39%)
BABA   74.35 (-0.43%)
AMD   122.36 (-1.20%)
T   16.45 (+0.92%)
F   10.48 (-1.04%)
MU   76.03 (-0.86%)
CGC   0.56 (-0.20%)
GE   119.79 (+0.78%)
DIS   92.95 (+0.49%)
AMC   6.96 (-2.93%)
PFE   30.04 (-0.13%)
PYPL   57.52 (-0.78%)
XOM   103.80 (+1.43%)

Oragenics (OGEN) News Today

$3.80
+0.10 (+2.70%)
(As of 09:34 AM ET)
Compare
Today's Range
$3.78
$3.80
50-Day Range
$2.94
$4.18
52-Week Range
$2.60
$12.54
Volume
1,162 shs
Average Volume
15,870 shs
Market Capitalization
$9.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SourceHeadline
MarketBeat logoStockNews.com Begins Coverage on Oragenics (NYSEAMERICAN:OGEN)
americanbankingnews.com - November 26 at 3:14 AM
MarketBeat logoOragenics (NYSEAMERICAN:OGEN) Research Coverage Started at StockNews.com
americanbankingnews.com - November 20 at 3:20 AM
finance.yahoo.com logoOragenics, Inc. (UAV.F)
finance.yahoo.com - November 6 at 1:34 PM
finance.yahoo.com logoOragenics Issues Update to Shareholders
finance.yahoo.com - November 2 at 10:15 AM
marketwatch.com logoOragenics Shares Rise 15% After Deal to Buy Some Odyssey Health Assets
marketwatch.com - October 5 at 2:21 PM
finance.yahoo.com logoOragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
finance.yahoo.com - October 5 at 9:19 AM
msn.com logoOragenics, AVITA Medical among healthcare movers
msn.com - October 2 at 1:46 PM
marketwatch.com logoStocks to Watch: Oragenics, Natuzzi, Syndax Pharmaceuticals
marketwatch.com - September 29 at 8:31 PM
finance.yahoo.com logoOragenics Enters into Agreement with Lantern Bioworks for Replacement-Therapy Assets
finance.yahoo.com - September 29 at 6:15 PM
finance.yahoo.com logoOragenics, Inc. Announces Private Placement
finance.yahoo.com - August 7 at 10:40 AM
finance.yahoo.com logoOragenics Project to Develop a Variant-Agnostic Protein Antigen for Use in its COVID-19 Intranasal Vaccine Receives Funding from CQDM
finance.yahoo.com - June 5 at 4:40 PM
finance.yahoo.com logoOragenics to Participate in the World Vaccine Congress Washington
finance.yahoo.com - March 29 at 1:49 PM
finance.yahoo.com logoOragenics Announces Positive Results in Several Lantibiotics Compounds Against MRSA and VRE
finance.yahoo.com - March 14 at 10:37 AM
finance.yahoo.com logoOragenics Appoints Janet Huffman as Chief Financial Officer Strengthening Executive Leadership Team
finance.yahoo.com - March 8 at 11:50 AM
finance.yahoo.com logoOragenics Looks To Boost Potency Of Its Nasal COVID-19 Vaccine With New Licensing Pact
finance.yahoo.com - March 1 at 2:38 PM
finance.yahoo.com logoOragenics Enters into an Exclusive Global License Agreement with Inspirevax to Develop Intranasal Covid Vaccine Candidate
finance.yahoo.com - March 1 at 9:37 AM
financialpost.com logoOragenics, Inc. Regains Compliance with NYSE American
financialpost.com - February 3 at 7:37 AM
finance.yahoo.com logoOragenics, Inc. Discloses One-for-Sixty Reverse Stock Split
finance.yahoo.com - December 23 at 4:15 PM
finance.yahoo.com logoOragenics Reports Favorable Toxicology Results for its COVID-19 Intranasal Vaccine Candidate
finance.yahoo.com - December 22 at 10:04 AM
finance.yahoo.com logoOragenics, Inc. Receives NYSE American Notice
finance.yahoo.com - December 20 at 6:16 PM
financialpost.com logoOragenics, Inc. Announces New Chair
financialpost.com - December 19 at 5:07 PM
finance.yahoo.com logoOragenics to Participate in the 2022 BioFlorida Annual Conference
finance.yahoo.com - October 24 at 5:18 PM
benzinga.com logoOral & Dental Probiotics Market Size & Shares by 2027 | Revenue, Cost Analysis, Gross Margins, Future Inv - Benzinga
benzinga.com - September 30 at 12:58 AM
morningstar.com logoOragenics Inc OGEN Stock Quote
morningstar.com - September 9 at 12:16 AM
reuters.com logoOGEN.P - Oragenics Inc | Stock Price & Latest News | Reuters
reuters.com - September 7 at 9:37 PM
reuters.com logoOGEN.A - Oragenics Inc | Stock Price & Latest News | Reuters
reuters.com - August 30 at 12:21 AM
benzinga.com logoOragenics Announces Preliminary Toxicology Data For Intranasal COVID-19 Vaccine Candidate; Says 'N T-CoV2 - Benzinga
benzinga.com - August 24 at 4:07 PM
businesswire.com logoOragenics Announces Favorable Preliminary Toxicology Data for Intranasal COVID-19 Vaccine Candidate - Business Wire
businesswire.com - August 24 at 10:39 AM
finance.yahoo.com logoOragenics Announces Favorable Preliminary Toxicology Data for Intranasal COVID-19 Vaccine Candidate
finance.yahoo.com - August 24 at 9:50 AM
seekingalpha.com logoOGN stock on watch after early toxicology data for intranasal COVID-19 shot (NYSE:OGN) - Seeking Alpha
seekingalpha.com - August 24 at 7:29 AM
marketscreener.com logoORAGENICS INC - 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. - Marketscreener.com
marketscreener.com - July 29 at 11:27 PM
marketscreener.com logoORAGENICS INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K) - Marketscreener.com
marketscreener.com - July 8 at 9:49 PM
marketscreener.com logoOragenics : Amendment to Statement of Changes in Beneficial Ownership (Form 4/A) - Marketscreener.com
marketscreener.com - June 27 at 5:16 PM
businesswire.com logoOragenics Appoints Seasoned Vaccine Executive Kimberly Murphy as President and Chief Executive Officer - Business Wire
businesswire.com - June 24 at 1:51 AM
marketwatch.com logoOragenics Shares up 8%, Co. Names New Pres, CEO
marketwatch.com - June 23 at 8:54 PM
seekingalpha.com logoOragenics names former GSK exec Kimberly Murphy as CEO
seekingalpha.com - June 23 at 8:54 PM
finance.yahoo.com logoOragenics Appoints Seasoned Vaccine Executive Kimberly Murphy as President and Chief Executive Officer - Yahoo Finance
finance.yahoo.com - June 23 at 5:21 PM
prnewswire.com logoInimmune's new CEO Alan Joslyn takes the helm - PR Newswire
prnewswire.com - June 21 at 10:54 AM
markets.businessinsider.com logoOragenics Publishes Intranasal Vaccine Candidate Studies In Scientific Journal
markets.businessinsider.com - June 16 at 12:44 AM
seekingalpha.com logoOragenics announces peer-reviewed positive data publication for nasal COVID shot candidate
seekingalpha.com - June 14 at 10:44 AM
benzinga.com logoOragenics Announces Publication Data For Its NT-CoV2-1 Intranasal COVID-19 Vaccine Candidate In Scientifi - Benzinga
benzinga.com - June 14 at 8:26 AM
businesswire.com logoOragenics Announces Publication of Positive Data for its NT-CoV2-1 Intranasal COVID-19 Vaccine Candidate in Scientific Reports - Business Wire
businesswire.com - June 14 at 8:26 AM
apnews.com logoOragenics: Q1 Earnings Snapshot - The Associated Press - en Español
apnews.com - May 15 at 12:03 AM
marketscreener.com logoOragenics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 - Marketscreener.com
marketscreener.com - May 14 at 6:36 PM
benzinga.com logoOragenics's Earnings: A Preview - Benzinga
benzinga.com - April 26 at 6:20 PM
businesswire.com logoOragenics to Participate at the World Vaccine Congress Washington 2022 - Business Wire
businesswire.com - April 19 at 2:32 PM
finance.yahoo.com logoOragenics to Participate at the World Vaccine Congress Washington 2022 - Yahoo Finance
finance.yahoo.com - April 18 at 7:50 AM
globenewswire.com logoVancomycin Market Size, Share [2022] | is Projected to Reach at a CAGR of 10.65% | Industry Demand, Growth Rate, Type & Applications, Revenue, Key Players | Market Status and Forecast Research | Business Research Insights - GlobeNewswire
globenewswire.com - April 11 at 4:39 AM
seekingalpha.com logoOragenics extends collaboration deal to develop vaccines against future COVID-19 variants - Seeking Alpha
seekingalpha.com - April 6 at 3:33 PM
finance.yahoo.com logoOragenics Extends Collaboration to Develop Vaccines against Future Variants of Coronaviruses
finance.yahoo.com - April 6 at 8:35 AM
Get Oragenics News Delivered to You Automatically

Sign up to receive the latest news and ratings for OGEN and its competitors with MarketBeat's FREE daily newsletter.



OGEN Media Mentions By Week

OGEN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OGEN
News Sentiment

0.00

0.75

Average
Medical
News Sentiment

OGEN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OGEN Articles
This Week

1

0

OGEN Articles
Average Week

Get Oragenics News Delivered to You Automatically

Sign up to receive the latest news and ratings for OGEN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NYSEAMERICAN:OGEN) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -